Filing Details

Accession Number:
0001127602-10-000996
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-06 12:00:00
Reporting Period:
2010-01-04
Filing Date:
2010-01-06
Accepted Time:
2010-01-06 18:03:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1097264 Allos Therapeutics Inc ALTH Pharmaceutical Preparations (2834) 541655029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190418 J Stephen Hoffman 11080 Circlepoint Road
Suite 200
Westminster CO 80020
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-04 25,428 $2.42 500,298 No 4 M Direct
Common Stock Disposition 2010-01-04 25,428 $6.54 474,870 No 4 S Direct
Common Stock Acquisiton 2010-01-05 45,428 $2.42 520,298 No 4 M Direct
Common Stock Disposition 2010-01-05 45,428 $6.64 474,870 No 4 S Direct
Common Stock Acquisiton 2010-01-06 45,429 $2.42 520,299 No 4 M Direct
Common Stock Disposition 2010-01-06 45,429 $6.78 474,870 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2010-01-04 25,428 $0.00 25,428 $2.42
Common Stock Stock Options (Right to Buy) Disposition 2010-01-05 45,428 $0.00 45,428 $2.42
Common Stock Stock Options (Right to Buy) Disposition 2010-01-06 45,429 $0.00 45,429 $2.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
227,143 2001-01-12 2010-01-12 No 4 M Direct
181,715 2001-01-12 2010-01-12 No 4 M Direct
136,286 2001-01-12 2010-01-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 400 Indirect Custodial Account
Common Stock 100 Indirect Custodial Account For Elizabeth Hoffman
Common Stock 100 Indirect Custodial Account For Margaret Hoffman
Common Stock 100 Indirect Custodial Account For Mary Evelyn Hoffman
Common Stock 100 Indirect Custodial Account For Michael Hoffman
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan and relate to the exercise of stock options which were scheduled to expire on January 12, 2010 and the sale of the underlying shares for tax and estate planning purposes.
  2. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.50 to $6.6075. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.57 to $6.70. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
  4. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.74 to $6.81. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.